2.5.4. Measurement of the treatment effect
This protocol is extracted from research article:
Efficacy and safety of mechanical thrombectomy for cardioembolic stroke
Medicine (Baltimore), Jan 15, 2021; DOI: 10.1097/MD.0000000000024340

All analyses will be conducted by using RevMan software (V5.4), we will select fixed effects model or random effects model to merge the outcome indicators in accordance with the results of heterogeneity test. The fixed effects model will be applied for data synthesis of low heterogeneity (I2 < 50%) while the random effects model will be conducted if the heterogeneity is significant (I2 ≥ 50%). It is considered that differences are statistically significant if the results of Z test show that P value is less than .05, and the 95% confidence intervals does not contain 0 (for continuous variables) or the 95% confidence intervals does not contain 1 (for dichotomous variables).

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.